Authors:
KELSO EJ
SPIERS JP
MCDERMOTT BJ
SCHOLFIELD CN
SILKE B
Citation: Ej. Kelso et al., RECEPTOR-MEDIATED EFFECTS OF ENDOTHELIN ON THE L-TYPE CA++ CURRENT INVENTRICULAR CARDIOMYOCYTES, The Journal of pharmacology and experimental therapeutics, 286(2), 1998, pp. 662-669
Authors:
KELSO EJ
SPIERS JP
MCDERMOTT BJ
SCHOLFIELD CN
SILKE B
Citation: Ej. Kelso et al., STIMULATION OF L-TYPE CA2-SELECTIVE ANTAGONIST, BQ-123, IN VENTRICULAR CARDIOMYOCYTES ISOLATED FROM RABBIT MYOCARDIUM( CURRENT BY THE ENDOTHELIN RECEPTOR A), Biochemical pharmacology, 55(6), 1998, pp. 897-902
Authors:
LLOYD A
AITKEN JA
HOFFMEYER UKO
KELSO EJ
WAKERLY EC
BARBER ND
Citation: A. Lloyd et al., ECONOMIC-EVALUATION OF THE USE OF NADROPARIN CALCIUM IN THE PROPHYLAXIS OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM IN SURGICAL PATIENTSIN ITALY, PharmacoEconomics, 12(4), 1997, pp. 475-485
Authors:
LLOYD AC
AITKEN JA
HOFFMEYER UK
KELSO EJ
WAKERLY EC
BARBER ND
Citation: Ac. Lloyd et al., ECONOMIC-EVALUATION OF THE USE OF NADROPARIN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS IN SWITZERLAND, The Annals of pharmacotherapy, 31(7-8), 1997, pp. 842-846
Citation: Dm. Mullan et al., INVOLVEMENT OF ENDOTHELIN (ET)A AND ETB RECEPTORS IN THE HYPERTROPHICEFFECTS OF ET-1 IN RABBIT VENTRICULAR CARDIOMYOCYTES, Journal of cardiovascular pharmacology, 29(3), 1997, pp. 350-359
Authors:
KELSO EJ
GERAGHTY RF
MCDERMOTT BJ
CAMERON CHS
NICHOLLS DP
SILKE B
Citation: Ej. Kelso et al., CHARACTERIZATION OF A CELLULAR-MODEL OF CARDIOMYOPATHY, IN THE RABBIT, PRODUCED BY CHRONIC ADMINISTRATION OF THE ANTHRACYCLINE, EPIRUBICIN, Journal of Molecular and Cellular Cardiology, 29(12), 1997, pp. 3385-3397
Authors:
KELSO EJ
GERAGHTY RF
MCDERMOTT BJ
TRIMBLE ER
NICHOLLS DP
SILKE B
Citation: Ej. Kelso et al., MECHANICAL EFFECTS OF ET-1 IN CARDIOMYOCYTES ISOLATED FROM NORMAL ANDHEART-FAILED RABBITS, Molecular and cellular biochemistry, 157(1-2), 1996, pp. 149-155
Authors:
SPIERS JP
KELSO EJ
MCDERMOTT BJ
SCHOLFIELD CN
SILKE B
Citation: Jp. Spiers et al., ENDOTHELIN-1 MEDIATED INHIBITION OF THE ACETYLCHOLINE-ACTIVATED POTASSIUM CURRENT FROM RABBIT ISOLATED ATRIAL CARDIOMYOCYTES, British Journal of Pharmacology, 119(7), 1996, pp. 1427-1437
Authors:
KELSO EJ
SPIERS JP
MCDERMOTT BJ
SCHOLFIELD CN
SILKE B
Citation: Ej. Kelso et al., EFFECTS OF ENDOTHELIN (ET) RECEPTOR-SELECTIVE AND NONSELECTIVE ANTAGONISTS ON ET-1-INHIBITED L-TYPE CA2+ CURRENTS IN VENTRICULAR CARDIOMYOCYTES ISOLATED FROM RABBIT MYOCARDIUM, British Journal of Pharmacology, 118, 1996, pp. 56-56
Citation: Ej. Kelso et al., CONTRACTILE EFFECTS OF ENDOTHELIN-1 AND ENDOTHELIN-3, MEDIATED BY ET(A) AND ET(B) RECEPTOR SUBTYPES, IN VENTRICULAR CARDIOMYOCYTES ISOLATEDFROM RABBIT MYOCARDIUM, British Journal of Pharmacology, 118, 1996, pp. 131-131
Citation: Ej. Kelso et al., ACTIONS OF THE NOVEL VASODILATOR, FLOSEQUINAN, IN ISOLATED VENTRICULAR CARDIOMYOCYTES, Journal of cardiovascular pharmacology, 25(3), 1995, pp. 376-386
Authors:
SPIERS JP
KELSO EJ
MCDERMOTT BJ
SCHOLFIELD CN
SILKE B
Citation: Jp. Spiers et al., THE EFFECTS OF ENDOTHELINS ON PEAK L-TYPE CALCIUM CURRENT IN RABBIT ISOLATED VENTRICULAR CARDIOMYOCYTES, Journal of physiology, 489P, 1995, pp. 167-167
Authors:
KELSO EJ
MCDERMOTT BJ
SILKE B
SPIERS JP
SCHOLFIELD CN
Citation: Ej. Kelso et al., ELECTROPHYSIOLOGICAL EFFECTS OF LOOP DIURETICS ON VENTRICULAR CARDIOMYOCYTES ISOLATED FROM RABBIT MYOCARDIUM, British Journal of Pharmacology, 115, 1995, pp. 74-74
Authors:
GERAGHTY RF
KELSO EJ
MCDERMOTT BJ
TRIMBLE ER
NICHOLLS DP
Citation: Rf. Geraghty et al., CHARACTERIZATION OF VENTRICULAR CARDIOMYOCYTES ISOLATED FROM RABBITS WITH EPIRUBICIN-INDUCED HEART-FAILURE, British Journal of Pharmacology, 115, 1995, pp. 75-75
Citation: Ej. Kelso et al., DIFFERENTIAL-EFFECTS OF PHOSPHODIESTERASE INHIBITORS ON ACCUMULATION OF CYCLIC-AMP IN ISOLATED VENTRICULAR CARDIOMYOCYTES, Biochemical pharmacology, 49(4), 1995, pp. 441-452
Citation: Ej. Kelso et al., CONTRACTILE, CHRONOTROPIC AND ELECTROPHYSIOLOGICAL EFFECTS OF THE NOVEL VASODILATOR, FLOSEQUINAN, British Journal of Pharmacology, 112, 1994, pp. 210000100-210000100
Authors:
KELSO EJ
MCDERMOTT BJ
SPIERS JP
SCHOLFIELD CN
SILKE B
Citation: Ej. Kelso et al., DIFFERENTIAL-EFFECTS OF NOVEL CARDIOTONIC AGENTS ON THE VENTRICULAR ACTION-POTENTIAL, British Journal of Pharmacology, 112, 1994, pp. 210000199-210000199
Citation: Ej. Kelso et al., CARDIOTONIC ACTIONS OF THE NOVEL VASODILATOR, FLOSEQUINAN, AND ITS METABOLITE, BTS-53554, IN ISOLATED VENTRICULAR CARDIOMYOCYTES, British Journal of Pharmacology, 110, 1993, pp. 160000117-160000117
Citation: Ej. Kelso et al., CARDIOTONIC ACTIONS OF SELECTIVE PHOSPHODIESTERASE INHIBITORS IN RAT ISOLATED VENTRICULAR CARDIOMYOCYTES, British Journal of Pharmacology, 110(4), 1993, pp. 1387-1394
Citation: Ej. Kelso et al., CONTRACTILE MECHANISMS OF THE NOVEL PHOSPHODIESTERASE INHIBITOR, HN-10200, IN ISOLATED RAT VENTRICULAR CARDIOMYOCYTES, British Journal of Pharmacology, 109, 1993, pp. 160000125-160000125